# New Four-Marker Blood Test Detects Pancreatic Cancer With 92% Accuracy, Even in Early Stages

*2026-03-24 00:01 UTC · Science · 1 min read*

> UPenn and Mayo Clinic researchers developed a four-biomarker blood test that detects pancreatic cancer with 91.9% accuracy, catching 87.5% of early-stage cases.

Researchers at the University of Pennsylvania and Mayo Clinic have developed a blood test that detects pancreatic cancer with 91.9% accuracy by combining four protein biomarkers. The test identified 87.5% of early-stage (I/II) cases — a critical advance for a disease where only 1 in 10 patients survive beyond five years due to late diagnosis.

Lead researcher Dr. Kenneth Zaret's team studied 672 individuals and identified two new blood markers — aminopeptidase N (ANPEP) and polymeric immunoglobulin receptor (PIGR) — that, when combined with existing markers CA19-9 and THBS2, dramatically improved detection. The test maintained just a 5% false positive rate and successfully distinguished cancer patients from those with non-cancerous conditions like pancreatitis.

## Sources

- [sciencedaily.com](https://www.sciencedaily.com/releases/2026/03/260323005540.htm)
- [nih.gov](https://www.nih.gov/news-events/nih-research-matters/progress-toward-blood-test-early-pancreatic-cancer)

---
TechTools News · https://techtools.cz/tools/news/article/1005-new-four-marker-blood-test-detects-pancreatic-cancer-with-92-accuracy-even-in
Česká verze: https://techtools.cz/tools/news/clanek/1040-novy-krevni-test-se-ctyrmi-markery-odhali-rakovinu-slinivky-s-92-presnosti-i-v
